1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Key Pharma News 05 OCTOBER 2015

Key Pharma News 05 OCTOBER 2015

  • October 2015
  • -
  • Espicom Business Intelligence
  • -
  • 26 pages

Industry Trend Analysis - Zalviso's EMA Approval Is A Vital First Step For AcelRx
Industry Trend Analysis - Novartis Deal Offers XOMA Recovery Opportunity
Industry Brief - GSK Exercises Option For Inhaled Therapeutics
Industry Trend Analysis - Teva Stands To Win In Allergan/Impax Patent Battle
Industry Brief - Amgen To Acquire Dezima Pharma
Industry Brief - Novo Nordisk To Build Facility In Iran
Industry Trend Analysis - Niche Market Positioning Ahead For Sun
Industry Trend Analysis - Patent Affirmation A Boon For Shire's Development
Industry Brief - Novartis Launches Affordable Medicines Portfolio
Industry Brief - Endo Completes Par Acquisition
Industry Trend Analysis - Teva Acquisition Shows Growing Role Of Medical IT
Industry Trend Analysis - Hostility Rises As Mylan's Bid To Acquire Perrigo Sees November Endpoint
Industry Trend Analysis - Astellas/Chromocell Agreement Increases Pipeline Diversity
Industry Trend Analysis - Aspen's Domestic Business Remains Key Despite Domination Of International Sales
Industry Brief - Merck's Marizev Approved In Japan
Industry Brief - Praluent Approved For Hypercholesterolaemia In EU
Industry Brief - AbbVie's Viekirax Approved In Japan For HCV GT1
Industry Brief - Leuplin 24-Week Depot Approved In Japan
Industry Brief - VivaGel BV Gains EU Marketing Approval
Industry Brief - FDA Grants Priority Review for Ofatumumab As Relapsed CLL Maintenance Therapy
Industry Trend Analysis - Otsuka's Long-Term Oncology Position Lies Beyond Current Portfolio
Industry Brief - FDA Accepts Amgen's Kyprolis sNDA For Priority Review In Relapsed MM
Industry Trend Analysis - ITI-007's Advantage Over Competitors Will Secure Schizophrenia Market Share
Industry Brief - FDA Approves Vraylar For Bipolar I Disorder And Schizophrenia
Industry Trend Analysis - Europe Offers New Revenue Streams For Intuniv
Industry Brief - FDA Approves Tresiba For Type I/II Diabetes
Industry Brief - Allergan, Mylan Launch Paliperidone Tablets
Industry Trend Analysis - Basaglar Will Struggle To Replicate Lantus Sales
Industry Brief - Copaxone Approved In Japan For Relapsing MS
Industry Brief - First Data From The Prostate Cancer Registry Released At ECC 2015
Industry Trend Analysis - Roche's Entry Into Checkpoint Inhibition Market Imminent
Industry Trend Analysis - Developing Successor To Humira Will Be Of Critical Importance To AbbVie
Industry Trend Analysis - Gilead Will Battle To Prevent HCV Market Share Erosion
Industry Trend Analysis - J&J's Long Sighted Approach Could Change HCV Market Dynamics
Industry Trend Analysis - Ocrelizumab Set To Fill Unmet Medical Need In PPMS
Industry Trend Analysis - Amgen And Allergan's Biosimilar Bevacizumab On Target For Blockbuster Status

Table Of Contents

Key Pharma News 05 OCTOBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Alcoholism and drug dependence and addiction, known as substance use disorders and rehabilitation treatments are classified as substance abuse treatment. Some of the common symptoms of drug abuse are ...

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • August 2016
  • by Industry ARC

Psychotherapeutic drugs are used to treat mental illnesses such as extreme mood swings, social withdrawal, long lasting depression, confused thinking, and suicidal thought. schizophrenia, bipolar disorder, ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.